Literature DB >> 1635748

Fetal intracardiac potassium chloride injection to avoid the hopeless resuscitation of an abnormal abortus: I. Clinical issues.

N B Isada1, P G Pryde, M P Johnson, M Hallak, W B Blessed, M I Evans.   

Abstract

OBJECTIVE: With the intention of preventing the attendant medical, ethical, and legal problems arising from the birth of live-born, anomalous fetuses, we initiated a program offering fetal intracardiac potassium chloride injection as an adjunctive measure in the setting of genetically indicated second-trimester abortion.
METHODS: A lethal fetal injection was offered to patients carrying chromosomally or structurally abnormal fetuses at 19-24 weeks' gestation who desired abortion. When the patient elected this procedure, real-time ultrasound guidance was used to inject 3-5 mL of potassium chloride (2 mEq/mL) directly into the fetal cardiac chambers, followed by observation of fetal heart activity to ascertain cessation. Labor was subsequently induced with uterotonic prostaglandins.
RESULTS: The procedure caused immediate cessation of fetal heart motion in 20 of 21 cases. There were no maternal complications. No fetuses were live-born.
CONCLUSIONS: Direct fetal intracardiac potassium chloride injection effectively causes immediate fetal cardiac arrest. This approach may be adopted in cases of abortion by labor-induction methods at advanced gestations to ensure that the abortus is stillborn.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1635748

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  Avoiding anomalous newborns: preemptive abortion, treatment thresholds and the case of baby Messenger.

Authors:  M L Gross
Journal:  J Med Ethics       Date:  2000-08       Impact factor: 2.903

2.  A new and more effective feticide technique in late termination of pregnancy: potassium chloride injection into the interventricular septum of the fetal heart.

Authors:  Sema Süzen Çaypınar; Süleyman Cemil Oğlak; İbrahim Polat; Kübra Kurt Bilirer; Salim Sezer; Zeynep Gedik Özköse; Sema Karakaş
Journal:  Arch Gynecol Obstet       Date:  2022-10-21       Impact factor: 2.493

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.